1 recruiting, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Acute Kidney Injury (AKI): new trials by email Literature Review of Acute Kidney Injury (AKI) trials Research Report on Acute Kidney Injury (AKI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory - Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) | Phase 3 | Recruiting | Vantive Health LLC | 40 | 2024-07-12 | 2026-10-05 |
| Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants Fenoldopam, 0.9%NS - Patent Ductus Arteriosus (PDA), Acute Kidney Injury (AKI) | Phase 2 / Phase 3 | Terminated | Medical College of Wisconsin | 1 | 2019-02-06 | 2022-09-16 |
Acute Kidney Injury (2) · Ductus Arteriosus, Patent (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Heart Defects, Congenital (1) · Heart Diseases (1)
Fenoldopam (1) · Saline Solution (1)
Medical College of Wisconsin (1) · Vantive Health LLC (1)
United States (2)